Lucía Lourido
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lucía Lourido has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Joshua LaBaer
Arizona State University
1 shared publication - Juan Casado-Vela
Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Pozuelo, 28223 Madrid, Spain
1 shared publication - Manuel Fuentes
University of Salamanca (Universidad de Salamanca)
1 shared publication - María González-González
Department of Medicine and General Cytometry Service-Nucleus, CIBERONC ISCIII, Cancer Research Center (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain
1 shared publication - Nieves Ibarrola
Centro de Investigación del Cáncer e Instituto de Biología Molecular y Celular del Cáncer (IBMCC), CSIC-Universidad de Salamanca, 37007 Salamanca, Spain
1 shared publication - Paula Díez
Department of Immunology, Leiden University Medical Center (LUMC), Leiden, The Netherlands
1 shared publication
Latest Publications
- Open Access
NAPPA as a Real New Method for Protein Microarray Generation
Nucleic Acid Programmable Protein Arrays (NAPPA) have emerged as a powerful and innovative technology for the screening of biomarkers and the study of protein-protein interactions, among others possible applications. The principal advantages are the high specificity and sensitivity that this platform offers. Moreover, compared to conventional protein microarrays, NAPPA technology avoids the necessity of protein purification, which is expensive and time-consuming, by substituting expression in situ with an in vitro transcription/translation kit. In summary, NAPPA arrays have been broadly employed in different studies improving knowledge about diseases and responses to treatments. Here, we review the principal advances and applications performed using this platform during the last years.
Open AccessNAPPA as a Real New Method for Protein Microarray Generation
Nucleic Acid Programmable Protein Arrays (NAPPA) have emerged as a powerful and innovative technology for the screening of biomarkers and the study of protein-protein interactions, among others possible applications. The principal advantages are the high specificity and sensitivity that this platform offers. Moreover, compared to conventional protein microarrays, NAPPA technology avoids the necessity of protein purification, which is expensive and time-consuming, by substituting expression in situ with an in vitro transcription/translation kit. In summary, NAPPA arrays have been broadly employed in different studies improving knowledge about diseases and responses to treatments. Here, we review the principal advances and applications performed using this platform during the last years.